Teladoc Health, Inc.’s (TDOC) Officers and Directors Accused of Failing to Disclose Conduct Violations to Investors
According to the complaint, Teladoc’s executives allowed multiple violations that hurt the company, including an inappropriate relationship between an executive and lower-level employee, insider trading, harassment of the Company’s employees, and retaliation against a whistleblower. Teladoc executives breached their fiduciary duties by misleading shareholders through materially false statements that failed to disclose this inappropriate activity and their lack of enforcement of Teladoc’s conduct policies. In December 2018, Southern Investigative Reporting Foundation published an article that revealed all of Teladoc executives’ violations. On this news, Teladoc stock fell $4.00, over 6.5%, to close at $55.81. As a result of their materially false and misleading statements, the CEO and CFO have been named as defendants in a securities fraud class action lawsuit that Teladoc is required to defend, further injuring shareholders.
Teladoc Health, Inc. (TDOC) Shareholders Have Legal Options
Concerned shareholders who would like more information about their rights and potential remedies can send us a message via the Shareholder Information below.
